Wilhelm Aicher

Prof. Wilhelm Aicher

Department of Urology, University of Tuebingen Hospital, Waldhoernlestr 22, D-72072 Tubingen, Germany
orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2008 in Nature
Verified
Journal Article
Closed access
PDF file
SCSabine Conrad
Sabine Conrad
MRMarkus Renninger
Markus Renninger
JHJörg Hennenlotter
Jörg Hennenlotter
TWTina Wiesner
Tina Wiesner
LJLothar Just
Lothar Just
TSThomas Skutella
Thomas Skutella

1 December 1986 in Cell
Verified
Journal Article
Open access
RSReinhard Schuh
Reinhard Schuh
Wilhelm AicherWilhelm Aicher
Wilhelm Aicher
UGUlrike Gaul
Ulrike Gaul
SCSerge Côte
Serge Côte
APAnette Preiss
Anette Preiss
HJHerbert Jäckle
Herbert Jäckle
Krüppel (Kr), a segmentation gene of Drosophila, encodes a protein sharing structural features of the DNA-binding "finger motif" of TFIIIA, a Xenopus transcription factor. Low-stringency hybridization of the Kr finger coding sequence revealed multiple copies of homologous DNA sequences in the genomes of Drosophila and other eukaryotes. Molecular analysis of one Kr-homologous DNA clone identified a developmentally regulated gene. Its product, a finger protein, relates to Kr by the invariant positioning of crucial amino acid residues within the finger repeats and by a stretch of seven amino acids connecting the finger loops, the "H/C link." This H/C link is conserved in several nuclear and chromosome-associated proteins of Drosophila and other eukaryotic organisms including mammals. Our results demonstrate a new subfamily of evolutionarily conserved nuclear and possibly DNA-binding proteins that again relate to a Drosophila segmentation gene as in the case of the homeo domain.

15 January 2009 in Stem Cells
Verified
Journal Article
Open access
PDF file
COChristiane A. Opitz
Christiane A. Opitz
ULUlrike M. Litzenburger
Ulrike M. Litzenburger
CLChristian Lutz
Christian Lutz
TLTobias V. Lanz
Tobias V. Lanz
ITIsabel Tritschler
Isabel Tritschler
MPMichael Platten
Michael Platten
Mesenchymal stem cells (MSC) display unique suppressive properties on T-cell immunity, thus representing an attractive vehicle for the treatment of conditions associated with harmful T-cell responses such as organ-specific autoimmunity and graft-versus-host disease. Toll-like receptors (TLR) are primarily expressed on antigen-presenting cells and recognize conserved pathogen-derived components. Ligation of TLR activates multiple innate and adaptive immune response pathways to eliminate and protect against invading pathogens. In this work, we show that TLR expressed on human bone marrow-derived MSC enhanced the immunosuppressive phenotype of MSC. Immunosuppression mediated by TLR was dependent on the production of immunosuppressive kynurenines by the tryptophan-degrading enzyme indoleamine-2,3-dioxygenase-1 (IDO1). Induction of IDO1 by TLR involved an autocrine interferon (IFN)-β signaling loop, which was dependent on protein kinase R (PKR), but independent of IFN-γ. These data define a new role for TLR in MSC immunobiology, which is to augment the immunosuppressive properties of MSC in the absence of IFN-γ rather than inducing proinflammatory immune response pathways. PKR and IFN-β play a central, previously unidentified role in orchestrating the production of immunosuppressive kynurenines by MSC.Disclosure of potential conflicts of interest is found at the end of this article.

1 July 2004 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
TGTatiana Gründer
Tatiana Gründer
CGChristoph Gaissmaier
Christoph Gaissmaier
JFJürgen Fritz
Jürgen Fritz
RSReinout Stoop
Reinout Stoop
PHPeter Hortschansky
Peter Hortschansky
Wilhelm AicherWilhelm Aicher
Wilhelm Aicher

1 December 2000 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
JDJan Domke
Jan Domke
SDSilke Dannöhl
Silke Dannöhl
WPWolfgang Parak
Wolfgang Parak
OMOtto Müller
Otto Müller
Wilhelm AicherWilhelm Aicher
Wilhelm Aicher
MRManfred Radmacher
Manfred Radmacher

6 December 2015 in Stem Cells International
Verified
Journal Article
Open access
PDF file
KEKourosch C. Elahi
Kourosch C. Elahi
GKGerd Klein
Gerd Klein
Meltem Avci-AdaliMeltem Avci-Adali
Meltem Avci-Adali
KSKarl D. Sievert
Karl D. Sievert
SMSheila MacNeil
Sheila MacNeil
Wilhelm AicherWilhelm Aicher
Wilhelm Aicher
When germ‐free cell cultures became a laboratory routine, hopes were high for using this novel technology for treatment of diseases or replacement of cells in patients suffering from injury, inflammation, or cancer or even refreshing cells in the elderly. Today, more than 50 years after the first successful bone marrow transplantation, clinical application of hematopoietic stem cells is a routine procedure, saving the lives of many every day. However, transplanting other than hematopoietic stem and progenitor cells is still limited to a few applications, and it mainly applies to mesenchymal stromal cells (MSCs) isolated from bone marrow. But research progressed and different trials explore the clinical potential of human MSCs isolated from bone marrow but also from other tissues including adipose tissue. Recently, MSCs isolated from bone marrow (bmMSCs) were shown to be a blend of distinct cells and MSCs isolated from different tissues show besides some common features also some significant differences. This includes the expression of distinct antigens on subsets of MSCs, which was utilized recently to define and separate functionally different subsets from bulk MSCs. We therefore briefly discuss differences found in subsets of human bmMSCs and in MSCs isolated from some other sources and touch upon how this could be utilized for cell‐based therapies.